News Conference News AHA 2022 Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI Yael L. Maxwell November 10, 2022
Presentation TCT 2022 Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial Presenter: Pablo Salinas September 19, 2022
Presentation TCT 2022 TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized… Presenter: Jonas Haener September 19, 2022
Presentation TCT 2022 TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry Presenter: Sang Yeub Lee September 19, 2022
Presentation TCT 2022 TCT 32: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients According to LV Dysfunction Status: Analysis from PTRG-DES(Platelet function and genoType-Related long-term proGnosis in DES-treated patients)… Presenter: Donghoon Han September 19, 2022
Presentation TCT 2022 TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent Presenter: Seung Hun Lee September 19, 2022
Presentation TCT 2022 TCT 30: Platelet Reactivity and Clinical Outcomes after Drug-Eluting Stent Implantation in East Asian Patients: Results from the PTRG-DES Consortium Presenter: Byeong-Keuk Kim September 19, 2022
Presentation TCT 2022 TCT 4: Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation Presenter: Johny Nicolas September 17, 2022
Presentation TCT 2022 TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry Presenter: KI-HYUN JEON September 17, 2022
Presentation TCT 2022 TCT 51: Assessment of Durable Polymer and Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Presenter: Gustavo Araújo September 17, 2022
Presentation TCT 2022 TCT 785: Unintentional Extraction of a Recently Implanted Drug Eluting Coronary Stent From the Left Main During Staged PCI to the Left Circumflex Presenter: Juan Ignacio Damonte September 17, 2022
News Conference News TVT 2022 More Support for Single Antiplatelet Therapy After TAVI Michael O'Riordan June 10, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Features Bloodlines: How Far Should Cardiologists Go in Treating Family? Todd Neale March 10, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
Video » Interview Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial September 19, 2022